Testing effectiveness (Phase 2)Study completedNCT01177007What this trial is testingIntra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid TumorsWho this might be right forLiver Neoplasms Yale University 50
Early research (Phase 1)Study completedNCT00002901What this trial is testingDocetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionWho this might be right forBreast CancerHead and Neck CancerLung Cancer+2 more City of Hope Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06209580What this trial is testingAMT-253 in Patients With Advanced Solid TumoursWho this might be right forMalignant MelanomaAdvanced Solid Tumors Multitude Therapeutics Inc. 96
Early research (Phase 1)Study completedNCT01920061What this trial is testingPF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)Who this might be right forNeoplasm Pfizer 110
Early research (Phase 1)Study completedNCT04319757What this trial is testingACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic CancerSolid Tumor+2 more Acepodia Biotech, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT07410676What this trial is testingEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsWho this might be right forCancerSarcomaLeukaemia+12 more Essen Biotech 83
Early research (Phase 1)Active Not RecruitingNCT02974738What this trial is testingA Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)Who this might be right forAdvanced Solid TumorsSolid TumorSolid Carcinoma+13 more Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 120
Early research (Phase 1)Study completedNCT01226316What this trial is testingSafety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment SchedulesWho this might be right forAdvanced Solid MalignancySafety and TolerabilityPharmacokinetics+11 more AstraZeneca 285
Early research (Phase 1)Ended earlyNCT02476955What this trial is testingOpen-label Phase 1b Study of ARQ 092 in Combination With AnastrozoleWho this might be right forSolid TumorsOvarian CancerEndometrial Cancer ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT04550494What this trial is testingMeasuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)UnknownNCT05094804What this trial is testingOR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer AgentsWho this might be right forCancerTumor, SolidMalignant Neoplasm+7 more OncoResponse, Inc. 172
Early research (Phase 1)Study completedNCT01239134What this trial is testingTrial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid TumorsWho this might be right forUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies Leap Therapeutics, Inc. 10
Not applicableWithdrawnNCT00334984What this trial is testingGlutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for SarcomaWho this might be right forChildhood Malignant Fibrous Histiocytoma of BoneSarcoma Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00005952What this trial is testingTemozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorHead and Neck Cancer+5 more Duke University 30
Testing effectiveness (Phase 2)Study completedNCT00405327What this trial is testingA Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell TransplantationWho this might be right forSarcomaNeuroblastomaWilm's Tumor University of Michigan Rogel Cancer Center 16
Not applicableUnknownNCT00072488What this trial is testingWhole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or LymphomaWho this might be right forLymphomaNeuroblastomaSarcoma American College of Radiology Imaging Network 226
Early research (Phase 1)Looking for participantsNCT06465069What this trial is testingLY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsWho this might be right forMetastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more Eli Lilly and Company 420
Testing effectiveness (Phase 2)Ended earlyNCT03094169What this trial is testingAVID100 in Advanced Epithelial CarcinomasWho this might be right forSolid Tumor, AdultTriple Negative Breast CancerHead and Neck Squamous Cell Carcinoma+1 more Formation Biologics 49
Not applicableStudy completedNCT01586104What this trial is testingIntensity-Modulated Radiation Therapy in Treating Younger Patients With Lung MetastasesWho this might be right forAdult RhabdomyosarcomaLung MetastasesMetastatic Ewing Sarcoma+9 more Ann & Robert H Lurie Children's Hospital of Chicago 20
Testing effectiveness (Phase 2)Study completedNCT00003406What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Cancer Treatment Centers of America 30